© 2004 by BMJ Publishing Group & British Cardiac Society
EDITORIAL
Endothelial progenitor cells and coronary artery disease
Correspondence to:
Correspondence to:
Dr Sheila Francis
Cardiovascular Research Unit, Division of Clinical Sciences North, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield S5 7AU, UK; s.francis{at}sheffield.ac.uk
Endothelial progenitor cells have radically altered the way in which vascular biologists and clinicians think about the genesis, development, and healing of atherosclerotic lesions.
Keywords: endothelial progenitor cells; stem cells; coronary artery disease
Abbreviations: EPC, endothelial progenitor cell; VEGF2R, vascular endothelial growth factor-2 receptor; VSMC, vascular smooth muscle cells
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
